One recent set of headlines noted that an experimental, cutting-edge drug for the difficult-to-treat disease hepatitis C isn’t looking good for FDA approval because there’s evidence it can harm patients without much helping them. That’s terrible news for hepatitis C sufferers, of course, but most of us might just shrug, figuring that’s exactly the sort […]
Mobile Site | Full Site
Get a free blog at WordPress.com Theme: WordPress Mobile Edition by Alex King.